Lopreeza (Amneal Pharmaceuticals of New York, LLC)
Welcome to the PulseAid listing for the Lopreeza drug offered from Amneal Pharmaceuticals of New York, LLC. This Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amneal Pharmaceuticals of New York, LLC |
| NON-PROPRIETARY NAME: | estradiol/norethindrone acetate |
| SUBSTANCE NAME: | ESTRADIOL; NORETHINDRONE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA],Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
Lopreeza HUMAN PRESCRIPTION DRUG Details:
| Item Description | Lopreeza from Amneal Pharmaceuticals of New York, LLC |
| LABELER NAME: | Amneal Pharmaceuticals of New York, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2014-10-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69238-1251_e1cb8ca9-c9bd-43ea-b000-0721b48d25d4 |
| PRODUCT NDC: | 69238-1251 |
| APPLICATION NUMBER: | NDA020907 |
Other ESTRADIOL; NORETHINDRONE ACETATE Pharmaceutical Manufacturers / Labelers:
